New York City, NY, Dec. 13, 2017 -- Persistence Market Research has published a new report global hyperthermia treatment for cancer market. According to the analysis of the report, the market is likely to rise at a significant growth rate during the tenure of forecast from 2017 to 2025. The report presents an in-depth analysis and future estimations that are based on current and historical performance of the market. From market drivers to growth challenges to opportunities to competitive strategies, analysts have covered each and every aspect that could influence the growth of this market over the forecast period of the market. The report not only provides quality insights, but also quantification of data through discussions with industry experts.
The revenue of the world hyperthermia treatment for cancer market is anticipated to be around US$160 mn by the end of the forecast period that stretches from 2017 to 2025, exhibiting a CAGR of 6.1% over the forecast period. The market for hyperthermia treatment for cancer has been projected to reach around US$99 mn in 2017.
Cancer has always been a much dreaded disease across the globe and its spread has been on constant rise. As World Health Organization (WHO) projects, an estimated number of fatalities resulting from cancer across the globe would reach 13.1 mn by 2030. WHO also indicated that the prevalence of cancer worldwide will reach around 75% from the year 2008 to 2030. With such rapid rise in the incidences of cancer, patients are increasingly opting for various cancer therapies. As such, this is going to increase the volume of patients seeking hyperthermia treatment thereby giving the market a push.
Get Research Report Sample: https://www.persistencemarketresearch.com/samples/14632
There has been an increasing awareness relating to the therapeutic effects that hyperthermia brings upon treatment of various malignant diseases. People are, as such, showing interest and undergoing hyperthermia treatment for malignant diseases thereby increasing the revenue for the market. Coupled with radiation therapy, hyperthermia has proved to be more effective and superior in the treatment of cancer as opposed to only radiation therapy. Thus, the market for hyperthermia treatment for cancer is anticipated to receive a boost from the advantages that are associated with the hyperthermia treatment.
However, there is high cost that is involved with the hyperthermia treatment for cancer. In comparison with various other methods of cancer treatment, hyperthermia treatment comes expensive. Besides, mostly hyperthermia treatment of cancer is taken in combination with radiation therapy or chemotherapy and this makes the treatment all the more expensive. As such, the high cost factor is impeding the growth of the market for hyperthermia treatment for cancer.
Browse Research Report ToC: https://www.persistencemarketresearch.com/market-research/hyperthermia-treatment-for-cancer-market/toc
The world hyperthermia treatment for cancer market has been classified on the basis of device type, end user, application and geography. The key segments based on device type include microwave hyperthermia device, ultrasound hyperthermia device, infrared therapy device, and shortwave therapy device. Of them, shortwave hyperthermia device segment is likely to rise at a CAGR of 7.0% over the forecast period.
In terms of geography, the world hyperthermia treatment for cancer market is classified into four key regions North America, Europe, Latin America, Asia Pacific, and Middle East and Africa (MEA). Of these regions, Asia Pacific is projected to offer a lucrative market for hyperthermia treatment for cancer. With huge population base, India and China have very high incidences of cancer. However, there is a dearth of proper facilities and experienced and qualified and practitioners in these nations. This is being dealt with both by the government and private sectors and they are trying come up with more of such facilities in these nations. Furthermore, there is an increasing willingness amongst the patients to seek therapeutic treatments for cancer thereby providing a lucrative market for therapeutic treatment for cancer.
Some of the leading players of the market for hyperthermia treatment for cancer are Celsius42+ GmbH, Yamamoto Vinita Co., Ltd, Pyrexar Medical Inc., Haifu Medical Technology Co. Ltd, Oncothermia, Andromedic Srl, Hydrosun GmbH, and a few others.
Get Full Copy of this Research Report: https://www.persistencemarketresearch.com/checkout/14632
Contact
Persistence Market Research
305 Broadway
7th Floor
New York City, NY 10007
United States
USA-Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Anta Sports Expands Global Footprint With Strategic Puma Stake
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



